Trial results

$ALKS — ALKS 7290

Alkermes plc. (ALKS) ALKS 7290: trial results in Attention-deficit hyperactivity disorder (ADHD) in adults, 2027.

Research by Catalyst Intel

The catalyst

"- Phase 2 Study of ALKS 7290 in Adults With ADHD is Enrolling, Data Expected in 2027 -"

— Alkermes plc, 8-K filed 2026-09-21 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id

ALKS-ALKS7290-2026

Company

Alkermes plc.

Kind

Trial results

Indication

Attention-deficit hyperactivity disorder (ADHD) in adults

Window

2027-01-01 – 2027-12-31

Status

slate

The bar

No bar has been published for this event yet.

Verdicts

Sealed with the bar. Any verdict for this event reaches this page on 2028-01-30; subscribers get it on the day.